Answers are grounded in this paper and cite their sources.
We report an efficient strategy for the asymmetric synthesis of trifluoromethyl-substituted cyclopropanes by means of myoglobin-catalyzed olefin cyclopropanation reactions in the presence of 2-diazo-1,1,1-trifluoroethane (CF 3 CHN 2 ) as the carbene donor. These transformations were realized using a two-compartment setup in which ex situ generated gaseous CF 3 CHN 2 is processed by engineered myoglobin catalysts expressed in bacterial cells. This approach was successfully applied to afford a variety of trans -1-trifluoromethyl-2-arylcyclopropanes in high yields (61–99%) and excellent diastereo- and enantioselectivity (97–99.9% de and ee ). Furthermore, mirror-image forms of these products could be obtained using myoglobin variants featuring stereodivergent selectivity. These reactions provide a convenient and effective biocatalytic route to the stereoselective synthesis of key fluorinated building blocks of high value for medicinal chemistry and drug discovery. This work expands the range of carbene-mediated transformations accessible via metalloprotein catalysts and introduces a potentially general strategy for exploiting gaseous and/or hard-to-handle carbene donor reagents in biocatalytic carbene transfer reactions.
No takes yet. Share an insight, caveat, or question.
Tinoco et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: